To examine immunotherapy-induced changes in proliferative cytotoxic CD4+ T cells, and how this relates to regulatory KLRG1 expression, we first examined them in our prior network single-cell analysis from the 3 trial patients with paired tumor and longitudinal blood (both before and after immunotherapy). This evidence concerns the gene KLRG1 and neoplasm.